Literature DB >> 25047691

Placental mRNA expression of angiopoietins (Ang)-1, Ang-2 and their receptor Tie-2 is altered in pregnancies complicated by preeclampsia.

D Kappou1, S Sifakis2, V Androutsopoulos3, A Konstantinidou4, D A Spandidos3, N Papantoniou5.   

Abstract

OBJECTIVE: To investigate the placental expression of angiopoietin (Ang)-1, Ang-2 and their receptor, Tie-2, in preeclampsia (PE) with or without intrauterine growth restriction (IUGR).
METHODS: Case-control study including placentas from 28 PE pregnancies, 30 PE-IUGR pregnancies and 40 controls. The expression status of the genes was evaluated by quantitative real-time PCR.
RESULTS: In both PE and PE-IUGR groups, compared to the control group, there was significantly higher expression of Ang-2 (p < 0.001) and Tie-2 (p = 0.008) and lower expression of Ang-1 (p = 0.001). The magnitude of the difference was similar for Ang-1 for both groups, whereas the magnitude of the differences was higher for Ang-2 and Tie-2 in PE-IUGR group compared to controls. Ang-2 and Tie-2 were correlated in both PE (r = 0.8602, p < 0.001) and PE-IUGR (r = 0.6342, p < 0.001) groups. In PE-IUGR group, Ang-1 was associated to Ang-2 (r = 0.3458, p = 0.0452) and Tie-2 (r = 0.4448, p = 0.0084). Log10Ang-1 but not Ang-2 was gestational age dependent (R2 = 0.40, p < 0.001). After conversion in Multiples of the Median (MoM) log10 MoM Ang-1 was reduced in the PE group (mean = -0.8181, p < 0.001) and the PE-IUGR group (mean = -1.2583, p < 0.001) compared to control group (mean = -0.0924). DISCUSSION: We have demonstrated increased placental expression of Ang-2 and Tie-2 along with lower expression levels of Ang-1 in pregnancies with PE and PE-IUGR.
CONCLUSION: The angiopoietin axis seems to be disrupted in PE pregnancies. Whether the results of this study represent the angiogenic imbalance observed in PE pregnancies or they are part of the pathophysiology of this condition has to be further investigated.
Copyright © 2014. Published by Elsevier Ltd.

Entities:  

Keywords:  Angiogenesis; Angiopoietin-1; Angiopoietin-2; Placenta; Preeclampsia; Tie-2

Mesh:

Substances:

Year:  2014        PMID: 25047691     DOI: 10.1016/j.placenta.2014.07.001

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  6 in total

1.  Celecoxib restores angiogenic factor expression at the maternal-fetal interface in the BPH/5 mouse model of preeclampsia.

Authors:  Dorien Reijnders; Chin-Chi Liu; Xinjing Xu; Anna M Zhao; Kelsey N Olson; Scott D Butler; Nataki C Douglas; Jenny L Sones
Journal:  Physiol Genomics       Date:  2018-03-09       Impact factor: 3.107

Review 2.  Molecular and cellular underpinnings of normal and abnormal human placental blood flows.

Authors:  Yingchun Li; Ramón A Lorca; Emily J Su
Journal:  J Mol Endocrinol       Date:  2017-11-02       Impact factor: 5.098

3.  Role of the angiopoietin/Tie system in pregnancy (Review).

Authors:  D Kappou; S Sifakis; A Konstantinidou; N Papantoniou; D A Spandidos
Journal:  Exp Ther Med       Date:  2015-02-09       Impact factor: 2.447

4.  Placental expression of PAPPA, PAPPA-2 and PLAC-1 in pregnacies is associated with FGR.

Authors:  Stavros Sifakis; Vasilis P Androutsopoulos; Artemis Pontikaki; Alexis Velegrakis; George I Papaioannou; Ourania Koukoura; Demetrios A Spandidos; Nikos Papantoniou
Journal:  Mol Med Rep       Date:  2018-03-09       Impact factor: 2.952

5.  Placental vascularity and markers of angiogenesis in relation to prenatal growth status in overnourished adolescent ewes.

Authors:  David J Carr; Anna L David; Raymond P Aitken; John S Milne; Pawel P Borowicz; Jacqueline M Wallace; Dale A Redmer
Journal:  Placenta       Date:  2016-08-19       Impact factor: 3.481

6.  Association of Angiopoietin Dysregulation in Placental Malaria with Adverse Birth Outcomes.

Authors:  Puspendra P Singh; Sneha Bhandari; Ravendra K Sharma; Neeru Singh; Praveen K Bharti
Journal:  Dis Markers       Date:  2020-01-13       Impact factor: 3.434

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.